Use of beta-blocking drugs in withdrawal states.
D014151:Anti-Anxiety Agents / Q000009:adverse effects; D001569:Benzodiazepines; D000431:Ethanol / Q000009:adverse effects; D006801:Humans; D009294:Narcotics / Q000009:adverse effects; D011433:Propranolol / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
D014151:Anti-Anxiety Agents; D009294:Narcotics; D001569:Benzodiazepines; D000431:Ethanol; D011433:Propranolol